1. Home
  2. DSWL vs ANL Comparison

DSWL vs ANL Comparison

Compare DSWL & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Deswell Industries Inc.

DSWL

Deswell Industries Inc.

N/A

Current Price

$3.56

Market Cap

56.7M

Sector

Industrials

ML Signal

N/A

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$1.15

Market Cap

52.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSWL
ANL
Founded
1987
2004
Country
Macau
Cayman Islands
Employees
N/A
N/A
Industry
Plastic Products
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
56.7M
52.0M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
DSWL
ANL
Price
$3.56
$1.15
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
16.4K
22.4K
Earning Date
11-13-2025
04-20-2026
Dividend Yield
5.97%
N/A
EPS Growth
20.23
N/A
EPS
0.78
N/A
Revenue
$65,664,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.93
$0.88
52 Week High
$4.48
$2.99

Technical Indicators

Market Signals
Indicator
DSWL
ANL
Relative Strength Index (RSI) 38.27 39.47
Support Level $3.53 $0.88
Resistance Level $3.64 $1.59
Average True Range (ATR) 0.12 0.19
MACD -0.03 -0.03
Stochastic Oscillator 7.94 38.15

Price Performance

Historical Comparison
DSWL
ANL

About DSWL Deswell Industries Inc.

Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: